OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Rajesh Vedhanayaki
- John A. Gonzales (ORCID: https://orcid.org/0000-0003-0558-9793)
- Brian Madow
- Radhika Thundikandy
- Ceren Soylu
- Alison B Coyne
- Nicholas Jackson (ORCID: https://orcid.org/0000-0001-9691-9561)
- Lim Ll
- Keren Chen
- Sivakumar R. Rathinam
- Thuy Doan
- Anuradha Vadakke Kanakath
- Deniz Oncel
- Eric B. Suhler
- Giulia Corradetti
- Edmund Tsui
- Hassan A. Al-Dhibi
- Nisha R. Acharya
- Srinivas R. Sadda
- Mai Alhelaly
- S. Bala Murugan
Institutions
- University of California, Los Angeles (US)
- Oregon Health & Science University (US)
- University of California, San Francisco (US)
- Tanta University (EG)
- Aravind Eye Hospital (IN)
- San Francisco Foundation (US)
- Doheny Eye Institute (US)
- King Khaled Eye Specialist Hospital (SA)
- Centre for Eye Research Australia (AU)
- Jacobs Institute (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1016/j.xops.2026.101106
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Eye Institute